Cisplatin (Pfizer Laboratories Div Pfizer Inc.)
Welcome to the PulseAid listing for the Cisplatin drug offered from Pfizer Laboratories Div Pfizer Inc.. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc. |
NON-PROPRIETARY NAME: | Cisplatin |
SUBSTANCE NAME: | CISPLATIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-04-19 |
END MARKETING DATE: | 0000-00-00 |
Cisplatin HUMAN PRESCRIPTION DRUG Details:
Item Description | Cisplatin from Pfizer Laboratories Div Pfizer Inc. |
LABELER NAME: | Pfizer Laboratories Div Pfizer Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 2012-04-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0069-0081_64db63dd-9e65-4c4e-937f-09a8ae9dcfab |
PRODUCT NDC: | 0069-0081 |
APPLICATION NUMBER: | ANDA091062 |
Other CISPLATIN Pharmaceutical Manufacturers / Labelers: